Impact of Frailty Syndrome on Early and Midterm Adverse Events in Patients With Acute Coronary Syndrome

15 June 2026 : Clinical Research

Radosław Wontor^{AEF 1}, Maria Łoboz-Rudnicka

^{BDEF 1,2*}, Bogusława Ołpińska

^{B 1,2}, Krzysztof D. Dudek

^{C 3}, Magdalena Lisiak

^{B 4,5}, Tomasz Bańkowski^{C 1}, Rafał Wyderka

^{D 1,2}, Barbara Brzezińska^{B 1}, Krystyna Łoboz-Grudzień

^{AD 1}, Joanna Jaroch

^{AD 1,2}

DOI: 10.12659/MSM.952737

Med Sci Monit 2026; 32:e952737

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Major cardiovascular and cerebrovascular events (MACCEs) at 6-month follow-up according to different frailty stages.

MACCEs at 6-month follow-up	Frailty syndrome			P*
MACCEs at 6-month follow-up	Moderate/severe (n=54)	Mild (n=83)	Absent (n=59)	P*
		9 (10.8%)
Myocardial infarction	1 (1.9%)	1 (1.2%)	1 (1.7%)	0.948
Stroke	0 (0.0%)	2 (2.4%)	0 (0.0%)	0.253
Recurrent revascularization	1 (1.9%)	0 (0.0%)	1 (1.7%)	0.474
		7 (8.4%)
* for moderate/severe frailty vs no frailty.

Back to the Article